Sanctioned Project(s) as Principal Investigator
Title: Discovery and Biological Evaluation of Novel Dual Inhibitors of DprE1 and InhAas Potential Anti-Tubercular Agents
Funding Agency: CRG - DST, New Delhi
Sanctioned on: February 2023 (Amount: 35 lakhs)
Co-PI: Prof. S Murugesan, Pharmacy department, BITS Pilani - Pilani Campus
Sanctioned Project(s) as Co-Principal Investigator
Title: Design, Synthesis and Evaluation of Novel Thiochromene Analogs as Potential Anti-leishmanial Agents
Funding Agency: CRG - DST, New Delhi
Sanctioned on: February 2023 (Amount: 40 lakhs)
PI: Prof. S Murugesan, Pharmacy department, BITS Pilani - Pilani Campus
Ongoing Project(s) as Principal Investigator
Title: Design, Synthesis and Biological Evaluation of 1,2,3-triazole Hybrids as Novel Quorum Sensing Inhibitors
Funding Agency: Council of Scientific & Industrial Research, New Delhi
Sanctioned on: April 2021 (Amount: 18. 5 lakhs)
Duration: 16 August 2021 to 15 August 2024
Completed Projects
| S.No. | Title of the project | Funding Agency | Amount | Duration | Project fellow | Investigator | |
| 1 | Development of novel anti-leishmanial analogues loaded with novel nano-formulations | Department of Biotechnology, New Delhi.(Indo-Spain Bilateral grant) | 13.00 lakhs | Apr. 2018 - Mar.2021 | N. Adi Narayana | Co-investigator | |
| 2 | Structure Based Rational Design and Synthesis of Mycobacterium tuberculosis inhibitors
| Department of Science & Technology, New Delhi. | 22.00 lakhs | Jan. 2014 - Dec.2017
| A. Suresh | Principal investigator | |
| 3 | Synthesis and Biological Activity of Various Triazoles as Effective Antifungal Agents | Department of Biotechnology, New Delhi. | 21.44 lakhs | Nov.2012 - Oct.2015 | A. Suresh | Principal investigator | |
| 4 | Synthesis and Pharmacological Evaluation of Bishomo(hetero) arylpiperazines as atypical antipsychotic agents | University Grants Commission, New Delhi. | 06.44 lakhs | Apr. 2011 – Mar.2014 | H.N. Nagesh | Principal investigator | |
| 5 | Synthesis and Pharmacological Evaluation of Various Indole Analogues for the Treatment of Schizophrenia | Department of Science & Technology, New Delhi. | 18.28 lakhs | Jul. 2010 – Aug. 2013 | Mahalakshmi Naidu | Principal investigator | |
| 6 | 3-Benzisoxazolyl piperidines and Quinoxalinyl Piperazines as Potential Atypical Antipsychotic Agents | University Grants Commission, New Delhi. | 04.94 lakhs | Jan. 2005 – Dec. 2007 | - | Co-investigator | |